Search results

• Ranked first in Barrons most sustainable international company listing

  We have recently been ranked first in the Most Sustainable International Company rankings by Barron’s.

• Validation of our 1.5°C Science Based Targets

  We have become one of only three major chemical companies in the world to have our 1.5°C Science Based Targets validated.

• Latin America

  In Latin America, we have a manufacturing site in Campinas, Brazil and six other sales offices within the region.

• Where we operate

  Every day our global team, across 37 countries, work together to inspire our customers.

• Focusing on D&I in Asia

  Colleagues in Asia have been leading a programme of raising awareness, building an inclusive culture, and driving inclusivity in recruitment.

• Investing in mRNA and gene therapy

  As the core of our lipid systems capability within the Health Care business, Avanti is primarily focused on developing innovative lipid-based products of unparalleled purity to address specific medical challenges that are not resolved by current technology.

• ASD Kaleka Mosaik Initiative Impact Fund

  We are contributing to the first Impact Fund of ASD, developed in partnership with Tides Foundation.

• Sustainable ways of working in R&D

  We are focused on aligning the work of our global R&D teams with the United Nations Sustainable Development Goals (SDGs).

• Externally validated avoided emissions

  The emissions savings of this new product were revealed during its sustainability assessment, part of the new way of working for our innovation teams to support our Commitment.

• Supporting Invisible Disabilities Week at Croda

  Learn how Croda supports Invisible Disabilities Week, promoting awareness and inclusivity for employees with hidden disabilities. Discover personal stories, like Sana Bell’s, and our commitment to creating a supportive workplace for everyone to thrive.

• Navigating the future of innovative ingredients

  As Croda celebrates 100 years of delivering Smart science to improve lives™, we’re also looking ahead. This Vision Report is a forward-looking guide to the trends that will reshape the speciality ingredients industry across the next quarter-century.

• 100 years of smart science: Celebrating Croda's centenary across the globe

  Join us as we celebrate Croda’s 100-year journey from a small family firm in Yorkshire to a global leader in sustainable innovation. Discover the science, stories, and people behind a century of improving lives.

• Making every minute count

  Take a look at how employees across the Croda Group have spent their 1% Club time helping their communities.

• International Day of Women and Girls in Science

  At Croda, we recognise that by championing gender equality in STEM, we can adopt a future where talent determines success; while promoting inclusivity, and empowering the next generation of female scientists, engineers, and innovators.

• Life at Croda

  Celebrate the amazing people who make Croda International unique. Dive into inspiring stories, innovative projects, and the value of Together that drives our mission Smart science to improve lives™.

• Record performance driven by accelerated strategic implementation

  Croda International results for the six months ended 30 June 2021

• Strategic review of Performance Technologies and Industrial Chemicals businesses

  The core objective will be to establish what ownership structure best serves this part of Croda’s business going forward, to create a stronger platform for its future growth.

• Strong strategic delivery built on resilient financial performance

  Croda 2020 full-year results, strong strategic delivery built on resilient financial performance

• Appointment of Non-Executive Director, Jill Anderson

  9 January2026: We are pleased to announce the appointment of Jill Anderson as Non-Executive Director.

• Sentient Science and Croda partner for wind asset life extension

  Croda announce a new partnership with Sentient Science for the recommended use of Croda’s Rewitec additives

• Construction underway on our new North American Headquarters and innovation centre

  The sustainable facility will bring together commercial and technical teams from across our business areas

• Supporting local school children during lockdown

  We are supporting school children in the UK by gifting our pre-owned laptops and tablets to pupils having lessons at home

• Croda urges G20 leaders to keep Paris Agreement within reach

  Croda is signatory to an open letter to all G20 leaders, urging them to keep the Paris Agreement’s 1.5°C goal within reach.

• Signatory to the if not now then when campaign

  We have joined over 70 major UK businesses in becoming a signatory to the Black inclusion business campaign.

• Celebrating our innovative ingredients: Zenakine™ - redefining neurocosmetic skincare possibilities

  8 September 2025: Croda International Plc (“Croda”), the company that uses smart science to create high-performance ingredients and solutions that improve lives, has recently launched Zenakine™, a biotech-based neuroactive ingredient designed to counteract the effects of stress on the skin.

• Croda Foundation

  We have taken a big step towards achieving our ambition of expanding the reach of our smart science to permanently improve more lives by funding the Croda Foundation.

• Collaboration to deliver new vaccine adjuvants

  In 2021 we established a strategic collaboration with the Danish government’s life science research institute, Statens Serum Institute (SSI).

• Responsible business

  /Images/Corporate/Corporate V2/Sustainability/Our commitment sustainability image

• Agroforestry in the Amazon

  The Croda Foundation is supporting an Instituto Amazonas agroforestry project, which aims to revive traditional agriculture practices among indigenous tribes, improving food security and protecting their cultural heritage and environment.

• Improving the customer experience in China

  Our .CN website transformation, which was launched in 2020, has created an entirely new online experience for customers in fast-growing Chinese markets.

• Supplying delivery systems to help prevent cardiovascular disease

  Nucleic acid-based therapies are the next big blockbuster drug class opening up exciting applications such as gene editing, where a patient’s genetic material can be modified to correct a disorder.

• Supporting the next generation of therapeutic vaccines

  Vaccine adjuvants are used to enhance immune response to an antigen, improving the overall efficacy of the vaccine and increasing protection against the target disease.

• Bringing anti-ageing benefits to make-up

  Developed through one of our Smart Partnerships, Majestem® Drypure™ from our beauty actives business, Sederma, brings anti-ageing and environmental protection benefits to make-up.

• Sustainability-linked revolving credit facility

  In 2019, we became one of the UK’s first large public companies to include a sustainability metric in a revolving credit facility (RCF), with targets in the seven-year agreement aligned with our 2030 Commitment to become Climate Positive.

• Collaboration to develop alternative vaccine adjuvants

  In 2021 we established a strategic collaboration with the Danish Government’s life science research institute, Statens Serum Institute (SSI).

• Investors

  Investor information including financial reporting and events.

• Investor seminar on our Life Sciences sector

  7 October 2019: Senior members of our management team provided a comprehensive overview of the Life Sciences sector, with a particular focus on our Health Care business.

• Acquisitions

  Commercialising and increasing our access to new ideas and technologies.

• Regulatory news

  Our most recent announcements to the stock exchange.

• About us

  We are the name behind high performance ingredients and technologies in some of the most successful brands in the world.

• Consumer Care business review

  Discover how Consumer Care is reinvigorating Beauty and enabling continued growth in Fragrances & Flavours. Exploring innovation, market trends, and strategic growth driving performance in this year’s annual report business review.

• Annual Report

  Find our 2023 Annual Report here

• Sustainability Impact Report

  Find our 2023 Sustainability Impact Report here

• Our business model

  Our business model is designed to create long-term, sustainable value.

• Investor overview

  Croda is a successful global company with 105 operations across 39 countries, a focused Life Sciences and Consumer Care company.

• Share price

  Detailed share charts.

• Our centenary

  2025 is Croda’s centenary year which provides an excellent opportunity to celebrate our rich history and reflect on the strong foundations it gives us for future success.

• Shareholder centre

  Useful information for Croda Shareholders.

• Shareholder information

  Keep up to date with shareholder and investor information.

• Launch of first report on biotechnology opportunities in the personal care market

  27 September 2022: The “Biotechnology: personal care market report” is the first in a series from Croda which aim to help other forward-thinking companies leverage the opportunities offered by biotechnology.